Results 51 to 60 of about 47,763 (123)

HEPÁTICAS DE LA RIOJA [PDF]

open access: yes, 1984
In this paper the list of the Hepaticae species and their distribution in La Rioja are reported.En este trabajo presentamos el catálogo de Hepáticas y su distribución de La ...
Mendiola, A., Fuertes Lasala, E.
core   +2 more sources

Regulación de la respuesta inmune durante el desarrollo de metástasis hepáticas por las células estrelladas hepáticas [PDF]

open access: yes, 2022
[ES] Las células estrelladas hepáticas (CEH) juegan un importante papel en la regulación de la respuesta inmune local durante el desarrollo de metástasis hepáticas.
Cano López, Sandra
core  

HEMANGIOENDOTELIOMA HEPÁTICO INFANTIL: DOS DESENLACES DIFERENTES

open access: yesMedicentro, 2015
Las lesiones vasculares hepáticas en la niñez son raras, pero no infrecuentes. Entre estas, los hemangiomas son los tumores hepáticos vasculares más frecuentes, y se presentan con mayor frecuencia en los primeros meses de vida; sus manifestaciones ...
Yagima Fleites García   +2 more
doaj  

SURGICAL OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH SYNCHRONOUS COLORECTAL LIVER METASTASES

open access: yesArquivos de Gastroenterologia
Context Colorectal cancer is the second most prevalent cancer worldwide, and the liver is the most common site of metastases. Surgical resection of colorectal liver metastases provides the sole possibility of cure and the best odds of long-term survival.
Rafael FONTANA   +5 more
doaj   +1 more source

Primary hepatic haemangiosarcoma in a pet rabbit (Oryctolagus cuniculus)

open access: yesVeterinary Record Case Reports, Volume 13, Issue 3, September 2025.
Abstract An 8‐year‐old, entire, female rabbit was presented in decompensated shock. Blood tests revealed a mild, highly regenerative anaemia (haemocrit: 24.6%; reticulocytes: 15.7%) and a significant elevation of alanine transaminase (183 IU/L). The radiographic examination showed widespread mineralisation of the entire abdominal cavity and a mass ...
Glenda Murciano   +3 more
wiley   +1 more source

NK cell neoplasias [PDF]

open access: yes, 2004
Review on NK cell neoplasias, with data on clinics, and the genes ...
Wong, KF
core   +1 more source

Stereotactic virtual navigation systems for percutaneous tumour [PDF]

open access: yes, 2023
Los sistemas de Navegación Virtual Estereotáctica (SNVE) permiten guiar al profesional a través de la anatomía del paciente hasta la lesión a tratar. Estos sistemas constan de diferentes tecnologías/elementos como programas de navegación, sistemas de ...
Faraldo Vallés, María José   +2 more
core   +1 more source

Equine fasciolosis due to Fasciola hepatica in the Community of Madrid (Spain): First report of a rare parasitic infection in horses

open access: yesVeterinary Record Case Reports, Volume 13, Issue 3, September 2025.
Abstract We reported for the first time a confirmed case of equine fasciolosis in the Community of Madrid (Spain). Here, we described the clinical presentation, diagnostic approach and treatment of the affected horse, as well as the seroprevalence of Fasciola hepatica in the equestrian centre where it was detected.
Carolina R. Sanz   +3 more
wiley   +1 more source

Artificial Intelligence in FIT‐Positive Colonoscopy: Balancing Detection Metrics and Clinical Impact

open access: yes
United European Gastroenterology Journal, Volume 14, Issue 2, March 2026.
Ignasi Puig, Maria Pellisé
wiley   +1 more source

Colectomy and Neoplasia Outcomes of Patients With Ulcerative Colitis Receiving Golimumab: A Post‐Authorisation Safety Study Using the Spanish ENEIDA Registry

open access: yesPharmacoepidemiology and Drug Safety, Volume 34, Issue 8, August 2025.
ABSTRACT Purpose Golimumab (GLM), an anti‐tumour necrosis factor alpha (anti‐TNFα) agent, is indicated for moderate to severe ulcerative colitis (UC). This post‐authorisation safety study evaluated the risk of colectomy due to intractable disease and advanced colonic neoplasia (high‐grade dysplasia and/or colorectal cancer) under real‐world conditions ...
Eugeni Domènech   +42 more
wiley   +1 more source

Home - About - Disclaimer - Privacy